Robert H. Gilman

Robert H. Gilman

Auto-generated profile, based on publicly available information

Robert H. Gilman

Department of International Health, Johns Hopkins Bloomberg School of Public Health Johns Hopkins University, Baltimore, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2014 in Respiratory Research
Verified
Journal Article
Open access
PDF file
MCMiguel A Chavez
Miguel A Chavez
NSNavid Shams
Navid Shams
LELaura E Ellington
Laura E Ellington
NNNeha Naithani
Neha Naithani
RGRobert H Gilman
Robert H Gilman
WCWilliam Checkley
William Checkley
Guidelines do not currently recommend the use of lung ultrasound (LUS) as an alternative to chest X-ray (CXR) or chest computerized tomography (CT) scan for the diagnosis of pneumonia. We conducted a meta-analysis to summarize existing evidence of the diagnostic accuracy of LUS for pneumonia in adults.

2 December 2013 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMayuko Saito
Mayuko Saito
SGSonia Goel-Apaza
Sonia Goel-Apaza
SESusan Espetia
Susan Espetia
DVDaniel Velasquez
Daniel Velasquez
LCLilia Cabrera
Lilia Cabrera
KRK. Roman
K. Roman
Background. Human noroviruses are among the most common enteropathogens globally, and are a leading cause of infant diarrhea in developing countries. However, data measuring the impact of norovirus at the community level are sparse. Methods. We followed a birth cohort of children to estimate norovirus infection and diarrhea incidence in a Peruvian community. Stool samples from diarrheal episodes and randomly selected nondiarrheal samples were tested by polymerase chain reaction for norovirus genogroup and genotype. Excretion duration and rotavirus coinfection were evaluated in a subset of episodes. Results. Two hundred twenty and 189 children were followed to 1 and 2 years of age, respectively. By 1 year, 80% (95% confidence interval [CI], 75%–85%) experienced at least 1 norovirus infection and by 2 years, 71% (95% CI, 65%–77%) had at least 1 episode of norovirus-associated diarrhea. Genogroup II (GII) infections were 3 times more frequent than genogroup 1 (GI) infections. Eighteen genotypes were found; GII genotype 4 accounted for 41%. Median excretion duration was 34.5 days for GII vs 8.5 days for GI infection (P = .0006). Repeat infections by the same genogroup were common, but repeat infections by the same genotype were rare. Mean length-for-age z score at 12 months was lower among children with prior norovirus infection compared to uninfected children (coefficient: −0.33 [95% CI, −.65 to −.01]; P = .04); the effect persisted at 24 months. Conclusions. Norovirus infection occurs early in life and children experience serial infections with multiple genotypes, suggesting genotype-specific immunity. An effective vaccine would have a substantial impact on morbidity, but may need to target multiple genotypes.

1 March 2003 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
HGHécTor H. García
HécTor H. García
RGRobert H. Gilman
Robert H. Gilman
AGArmando E. Gonzalez
Armando E. Gonzalez
MVManuela Verastegui
Manuela Verastegui
SRSilvia Rodriguez
Silvia Rodriguez
MTMarco Tovar
Marco Tovar
The prevalence and characteristics of human taeniasis/cysticercosis and porcine cysticercosis were assessed in an endemic area of the Peruvian highlands. Individuals from 10 communities had stool examinations (N = 2,951) and serologic testing for Taenia solium antibodies (N = 2,583). The total porcine population present (N = 703) was also examined by serology. Cysticercosis is hyperendemic in this area and is associated with an important number of seizure cases. Human seroprevalence by village ranged from 7.1–26.9% (mean, 13.9%). Seroprevalence was higher among individuals with a history of seizures but not in those reporting a history of headache or intestinal taeniasis. Prevalence of taeniasis ranged from 0–6.7% (median, 2.5%). Coproantigen detection found 2.4 times more taeniasis cases than did microscopy (direct and after concentration). Age distribution for taeniasis showed a peak at younger ages than for seroprevalence. Porcine seroprevalence ranged from 42–75%. Random effects logistic regression models for human seropositivity demonstrated both in-house clustering of cases and a large increase in risk associated with a tapeworm carrier in the house. Besides confirming the close relationship between taeniasis and cysticercosis cases, this large-scale field study demonstrated early age of tapeworm and cysticercosis infections in humans, and short duration of taeniasis infections.

1 August 2013 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
ASAaron M Samuels
Aaron M Samuels
ECEva H Clark
Eva H Clark
GGGerson Galdos-Cardenas
Gerson Galdos-Cardenas
RWRyan E Wiegand
Ryan E Wiegand
LFLisbeth Ferrufino
Lisbeth Ferrufino
WPWorking Group on Chagas Disease in Bolivia and Peru
Working Group on Chagas Disease in Bolivia and Peru
Chagas disease control campaigns relying upon residual insecticide spraying have been successful in many Southern American countries. However, in some areas, rapid reinfestation and recrudescence of transmission have occurred. We conducted a cross-sectional survey in the Bolivian Chaco to evaluate prevalence of and risk factors for T. cruzi infection 11 years after two rounds of blanket insecticide application. We used a cubic B-spline model to estimate change in force of infection over time based on age-specific seroprevalence data. Overall T. cruzi seroprevalence was 51.7%. The prevalence was 19.8% among children 2–15, 72.7% among those 15–30 and 97.1% among participants older than 30 years. Based on the model, the estimated annual force of infection was 4.3% over the two years before the first blanket spray in 2000 and fell to 0.4% for 2001–2002. The estimated annual force of infection for 2004–2005, the 2 year period following the second blanket spray, was 4.6%. However, the 95% bootstrap confidence intervals overlap for all of these estimates. In a multivariable model, only sleeping in a structure with cracks in the walls (aOR = 2.35; 95% CI = 1.15–4.78), age and village of residence were associated with infection. As in other areas in the Chaco, we found an extremely high prevalence of Chagas disease. Despite evidence that blanket insecticide application in 2000 may have decreased the force of infection, active transmission is ongoing. Continued spraying vigilance, infestation surveillance, and systematic household improvements are necessary to disrupt and sustain interruption of infection transmission. Despite significant gains in the reduction of the burden of Chagas disease in many South American countries, active transmission and significant burden remain in areas such as the Gran Chaco. High initial vector density, poor housing material, peridomestic infestation, insecticide resistance, and a lack of systematic insecticide spraying and vector surveillance have previously been incriminated for failure to interrupt and sustain interruption of transmission. We conducted a census, seroprevalence, and epidemiologic study in a rural area in the Bolivian Chaco. The prevalence of infection was almost 20% in children and over 80% in adults. We estimated the intensity of transmission over time based on infection prevalence by age. We found that after the first spray program, transmission appeared to fall transiently but then increased again quickly. Sleeping in a structure with cracks in the walls, age and village of residence were associated with increased likelihood of infection. These findings suggest that consistently repeated systematic spraying campaigns accompanied by housing improvements are necessary to interrupt and sustain interruption of vector-borne transmission.

1 March 2000
Verified
Journal Article
Closed access
LCL Caviedes
L Caviedes
TLT S Lee
T S Lee
RGR H Gilman
R H Gilman
PSP Sheen
P Sheen
ESE Spellman
E Spellman
SMS Montenegro-James
S Montenegro-James

30 June 2021 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
RTRashmi Tippalagama
Rashmi Tippalagama
ASAkul Singhania
Akul Singhania
PDPaige Dubelko
Paige Dubelko
CACecilia S. Lindestam Arlehamn
Cecilia S. Lindestam Arlehamn
ACAustin Crinklaw
Austin Crinklaw
JBJulie G. Burel
Julie G. Burel
Upon Ag encounter, T cells can rapidly divide and form an effector population, which plays an important role in fighting acute infections. In humans, little is known about the molecular markers that distinguish such effector cells from other T cell populations. To address this, we investigated the molecular profile of T cells present in individuals with active tuberculosis (ATB), where we expect Ag encounter and expansion of effector cells to occur at higher frequency in contrast to Mycobacterium tuberculosis–sensitized healthy IGRA+ individuals. We found that the frequency of HLA-DR+ cells was increased in circulating CD4 T cells of ATB patients, and was dominantly expressed in M. tuberculosis Ag–specific CD4 T cells. We tested and confirmed that HLA-DR is a marker of recently divided CD4 T cells upon M. tuberculosis Ag exposure using an in vitro model examining the response of resting memory T cells from healthy IGRA+ to Ags. Thus, HLA-DR marks a CD4 T cell population that can be directly detected ex vivo in human peripheral blood, whose frequency is increased during ATB disease and contains recently divided Ag-specific effector T cells. These findings will facilitate the monitoring and study of disease-specific effector T cell responses in the context of ATB and other infections.